InspireMed-Blog-Oppurtunity-for-Pharma-Companies-Header InspireMed-Blog-Oppurtunity-for-Pharma-Companies-Header
AI Insights

Ask the data a question: How AI is reshaping analytics for pharma.

12th November 2026

|

Gabriel Warwick

For years, data has reached pharmaceutical teams the same way. A report lands. A dashboard refreshes. A bespoke request goes into a queue. Each still has its place, but each puts a layer between the person with the question and the answer they need.

AI removes that layer

From Reading Reports to Asking Questions

The real shift is not faster analysis, although you get that too. It is that information becomes something you can explore in conversation. You ask a question in plain English and get a full answer. Then you ask the next question, and the next, until you understand the picture well enough to act on it.

That is the thinking behind Meridian, our AI platform. Through a chat interface, a brand manager, a market access lead or a field team can put a question directly to the data and follow the thread wherever it leads. No ticket, no waiting, no hunting through tabs for the one chart that matters.

Why the foundations matter more, not less

AI is only as good as what sits underneath it. AI makes data quality, clear definitions and an honest account of limitations more important than ever, because a confident answer built on shaky ground is worse than no answer at all. In pharma, privacy, appropriate use and expert judgement must stay central to how these tools are built and used. We would rather Meridian say “the data cannot tell you that” than guess.

Our approach

We combine what AI makes possible with the sector knowledge and analytical expertise that give information its context. AskMeridian is where that combination becomes something you can actually use.

The future of data and analytics, as we see it, is more accessible, more interactive and much closer to the questions our clients need answered.

12th November 2026

|

Gabriel Warwick

Related Articles